Medical Education Library

Clinical Therapeutics for Atopic Dermatitis and Fungal Infections: An Update


 

A supplement to Skin & Allergy News.
This supplement was supported by PharmaDerm®
The articles in this supplement are based on presentations made during Skin Disease Education Foundation's 31st Annual Hawaii Dermatology Seminar, a continuing medical education program, on March 6, 2007, in Maui, Hawaii.


Topic Highlights/Faculty
Target Audience


To view the supplement, click the image above.

Topic Highlights/Faculty

Topical Steroids in Pediatric Atopic Dermatitis
Leon H. Kircik, MD
Associate Clinical Professor of Dermatology
Indiana University Medical Center
Indianapolis, Ind.
Medical Director
Derm Research, PLLC
Louisville, Ky.
Dr. Kircik has received funding for clinical grants from and is a consultant to Abbott Laboratories, Acambis, Allergan, Inc., Amgen Inc., Astellas Pharma US (Fujisawa), Berlex, Inc., Biogen-Idec, Inc., Breckenridge Pharmaceutical, Centocor, Inc., CollaGenex, Inc., CombiMatrix Corporation, Connetics Corporation, Coria Laboratories, Dermik Laboratories, Dowpharma, Ferndale Laboratories, Galderma Laboratories, L.P., Genentech Inc., GlaxoSmith Kline, Healthpoint Ltd., Intendis GmbH, 3M Pharmaceuticals, Medicis Pharmaceutical Corporation, Novartis Pharmaceuticals Corporation, Nucryst Pharmaceuticals, OrthoNeutrogena Corporation, PharmaDerm, QLT Inc., QuatRx Pharmaceuticals, Serono S.A., SkinMedica, Inc., and Stiefel Laboratories, Inc. Dr. Kircik has indicated that he will not include reference to off-label/investigational uses of drugs or devices in his article.


Topical Antifungals: An Update
Douglas W. Kress, MD
Chief of Pediatric Dermatology
Children's Hospital of Pittsburgh
Pittsburgh, Penn.
Dr. Kress has received honoraria, grant funding, and has served on the advisory board for PharmaDerm. Dr. Kress has indicated that he will not include reference to off-label/investigational uses of drugs or devices in his article.
Target Audience

This activity is intended for health care professionals, including dermatologists and pediatricians, who are involved in the treatment of patients with atopic dermatitis.


Copyright © 2007 Elsevier Inc.

Recommended Reading

Look Beyond Wrinkles in Aging Faces
MDedge Dermatology
Competing Botulinum Toxin Formulations May Pressure Price Down
MDedge Dermatology
Research Base for Cosmeceuticals Expands
MDedge Dermatology
Drain Abscesses, Get Cultures in Pediatric Skin, Soft Tissue Infections
MDedge Dermatology
Emerging Insights and New Therapeutic Opportunities: Acne and Atopic Dermatitis
MDedge Dermatology
Recent Advances in the Management of Atopic Dermatitis
MDedge Dermatology
Cosmeceutical Critique Compendium
MDedge Dermatology
Highlights of a SymposiumThe Role of Natural Ingredients in Dermatology
MDedge Dermatology
Roundup on Cosmetic DermatologyWinter 2007
MDedge Dermatology
Clearing Psoriasis: The Role of a Novel 2-Compound Ointment as First-Line Therapy
MDedge Dermatology